You can pass your annual physical with flying colors — weight fine, BMI fine — and still be carrying the one kind of fat most closely tied to metabolic disease, unmeasured. Not because anyone missed it on purpose. Because the tools in the room — a scale, a BMI chart, sometimes a tape measure — cannot see it.
It isn't the fat you can grab. It's deeper than that, it behaves differently from every other fat in your body, and hormones decide where it goes. Here is what it is, why it moves, and how we actually measure it.
Two kinds of fat
The fat under your skin is called subcutaneous fat. It's the fat you can pinch. Its main job is energy storage, and by fat standards, it is relatively quiet.
Visceral fat is a different tissue in a different place. It sits inside the abdomen, beneath the wall of abdominal muscle, packed into the omentum — the fatty apron that drapes over the intestines — and around organs like the liver. You can't pinch it, and you can't see it in a mirror.
That location is the whole story. Two people can share a height, a weight, and a BMI and carry very different risk, because one stores fat on the hips and thighs and the other stores it around the organs. Fat carried in the abdomen carries greater cardiometabolic risk than the hips-and-thighs pattern. Same number on the scale. Different biology.
Fat is a hormone gland
Fat tissue is not inert storage. It is an endocrine organ — a gland — releasing signaling proteins called adipocytokines that act locally and throughout the body. Three of them explain a lot:
Leptin is fat's fullness signal to the brain. It rises as fat mass rises — but in obesity, the brain stops responding to it. The signal gets louder; nobody hears it. That's leptin resistance.
Adiponectin is one of the good signals: it improves insulin sensitivity and calms inflammation. Unusually for a fat hormone, it falls as fat grows — and lower levels are associated with insulin resistance, abnormal cholesterol, and atherosclerosis.
Omentin is made preferentially by visceral fat itself, and it helps insulin work. Its levels drop in obesity, insulin resistance, and type 2 diabetes — visceral fat loses one of its own brakes.
Put together, this is why excess visceral fat tracks so consistently with insulin resistance, abnormal lipids, higher blood pressure, and chronic low-grade inflammation. It is an organ problem, not a willpower problem.
Why menopause moves it
Where fat goes is directed by sex hormones. Premenopausal women tend to store fat peripherally — under the skin, on the hips and thighs. Men carry more visceral fat. Estrogen is a big part of that difference: it favors the hips-and-thighs pattern and keeps visceral fat lower.
So when estrogen falls, the pattern changes. The Endotext chapter on endocrine changes in obesity states it plainly: visceral fat tissue increases in low-estrogen states, as seen in menopause. Estrogen deficiency also promotes the metabolic dysfunction that predisposes to metabolic syndrome and type 2 diabetes. Women with PCOS show a version of the same shift — researchers describe it as a masculinization of the fat tissue, with more of it stored viscerally and the metabolic complications that follow.
Men have their own loop: low testosterone means less muscle and more visceral fat, and more fat means more conversion of testosterone to estrogen, which lowers testosterone further. It runs in both sexes, in both directions.
The point for my patients: a waist that grows at menopause while the scale barely moves is a hormone signal. It deserves measurement, not blame.
The cortisol your blood test can't see
Here is a puzzle patients bring me often: if stress hormones drive belly fat, why is the cortisol level normal? In obesity, blood cortisol usually is normal. But fat tissue runs its own local cortisol economy. An enzyme called 11β-HSD1, highly expressed in fat, converts inactive cortisone into active cortisol right inside the tissue — and visceral fat cells carry more cortisol receptors than subcutaneous fat cells do. Activating those receptors drives inflammation and disrupts fat's hormone signals, feeding insulin resistance.
To be precise about what the evidence does and doesn't say: whether cortisol actually concentrates inside human visceral fat is unproven — the Endotext authors call it "possible, but unlikely." What is better supported is the machinery: local production plus extra receptors, a system tuned to hear cortisol loudly even when the blood level looks ordinary. At the extreme, Cushing's syndrome — true cortisol excess — redistributes fat from the limbs to the trunk and increases visceral fat, which is why clinicians take the connection seriously. Growth hormone drifts down as visceral fat climbs, too. One more hormone in the loop.
How we actually measure it
BMI cannot see any of this. It divides weight by height; it cannot tell fat from muscle, and it cannot say where the fat sits. A body-composition DXA scan (often written DEXA) — the same technology used for bone density — can. Two low-dose X-ray energies separate bone, fat, and lean tissue region by region, and the visceral fat number is built from the belly region: the software estimates the subcutaneous fat there and subtracts it from the total, leaving the visceral estimate.
That estimate has been checked against CT, the reference standard, and it tracks closely (a correlation of 0.93 in the validation literature), at a fraction of the radiation — a whole-body scan is about 4–5 microsieverts, less than a single day of natural background radiation. In my practice, whole-body DEXA is how we measure visceral fat rather than guessing at it from a waistline.
Visceral fat is reported as an area, in square centimeters. The ranges researchers use: around 100 cm² is where metabolic risk appears to rise, and above 160 cm² is considered high; in studies of women, values over roughly 100–110 cm² were associated with a less favorable metabolic profile. Read those as suggested ranges, not bright lines — they come from cross-sectional studies, the cutoffs are still being refined, and they also appear to differ by sex and ancestry. Context for a conversation, never a diagnosis on their own. What the research does support: visceral fat predicted mortality better than subcutaneous fat or ratio measures, and people with a completely normal BMI can still carry increased visceral fat and more risk than a tape measure would ever suggest — thin on the outside, fat on the inside.
The same scan reads the other half of the story. After age 50, muscle mass falls by roughly 1–2% a year. High fat with low muscle is called sarcopenic obesity; add low bone and it becomes osteosarcopenic obesity — and a scale sees none of it. One practical detail: because meals, exercise, and hydration shift the readings, a scan done fasting, under the same conditions each time, is the one you can trust for tracking change.
The least interesting number in the room
Measure where the fat is. Protect the muscle next to it. The scale was never the point — it's the least interesting number in the room, and for visceral fat, it was never even measuring the right thing.
— Pooja Singh, MD
This post is educational and is not personalized medical advice. Body-composition testing — and what any result means for you — is a decision to make with your own care team.
Sources
Ylli D, Sidhu S, Parikh T, Burman KD. Endocrine Changes in Obesity. In: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; updated September 6, 2022. NCBI Bookshelf NBK279053. https://www.ncbi.nlm.nih.gov/books/NBK279053/
Shepherd JA, Ng BK, Sommer MJ, Heymsfield SB. Body Composition by DXA. Bone. 2017;104:101–105. https://pmc.ncbi.nlm.nih.gov/articles/PMC5659281/
Messina C, Albano D, Gitto S, Tofanelli L, Bazzocchi A, Ulivieri FM, Guglielmi G, Sconfienza LM. Body Composition with Dual Energy X-Ray Absorptiometry: From Basics to New Tools. Quantitative Imaging in Medicine and Surgery. 2020;10(8). https://pmc.ncbi.nlm.nih.gov/articles/PMC7378094/
Reading this with your own health in mind? Start with a free Fit Call.

